When BDNF was attached to the OX26 antibody using the biotin-streptavidin conjugation method for the treatment of stroke, it was seen that there was a nearly 243 percent increase in motor activity compared to BDNF delivered alone [82]. The gene discussed is BDNF; the disease is stroke disorder.